Compare GAIN & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | GAIN | THW |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | 70 | N/A |
| Industry | Finance: Consumer Services | Finance Companies |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 558.3M | 513.9M |
| IPO Year | N/A | 2015 |
| Metric | GAIN | THW |
|---|---|---|
| Price | $14.99 | $12.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $14.75 | N/A |
| AVG Volume (30 Days) | ★ 335.2K | 90.0K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | ★ 10.22% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.07 | N/A |
| Revenue Next Year | $7.32 | N/A |
| P/E Ratio | $4.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.14 | $10.10 |
| 52 Week High | $15.25 | $13.19 |
| Indicator | GAIN | THW |
|---|---|---|
| Relative Strength Index (RSI) | 65.46 | 60.22 |
| Support Level | $13.69 | $12.33 |
| Resistance Level | N/A | $12.95 |
| Average True Range (ATR) | 0.31 | 0.27 |
| MACD | 0.05 | 0.10 |
| Stochastic Oscillator | 98.29 | 98.84 |
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.